End in sight for sickle-cell disease

Scientists at Stanford University School of Medicine have used a gene editing tool to repair the gene that causes sickle-cell disease in stem cells taken from diseased patients - paving the way for a cure for the disease, which affects up to 5million people globally. "We've finally shown that we can do it," said Matthew Porteus, senior author of the report on the study, published in the journal Nature.